ACICLOVIR CUVE 200 mg COMPRIMIDOS EFG Spanien - spanska - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

aciclovir cuve 200 mg comprimidos efg

laboratorios perez gimenez s.a. - aciclovir - comprimido - 200 mg - aciclovir 200 mg - aciclovir

ZOVIRAX 400 mg/5 ml SUSPENSION ORAL Spanien - spanska - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zovirax 400 mg/5 ml suspension oral

glaxosmithkline s.a. - aciclovir - suspensiÓn oral - 400 mg/5 ml - aciclovir 80 mg - aciclovir

ZOVIRAX 200 mg COMPRIMIDOS DISPERSABLES Spanien - spanska - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zovirax 200 mg comprimidos dispersables

glaxosmithkline s.a. - aciclovir - comprimido dispersable - 200 mg - aciclovir 200 mg - aciclovir

ACICLOVIR CINFA 200 MG COMPRIMIDOS EFG Spanien - spanska - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

aciclovir cinfa 200 mg comprimidos efg

laboratorios cinfa s.a. - aciclovir - comprimido - 200 mg - aciclovir 200 mg - aciclovir

ACICLOVIR TEDEC 25 mg/ml SOLUCION PARA PERFUSION EFG Spanien - spanska - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

aciclovir tedec 25 mg/ml solucion para perfusion efg

meiji pharma spain s.a. - aciclovir - soluciÓn para perfusiÓn - 250 mg - aciclovir 25 mg - aciclovir

Tysabri Europeiska unionen - spanska - EMA (European Medicines Agency)

tysabri

biogen netherlands b.v. - natalizumab - esclerosis múltiple - inmunosupresores selectivos - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 y 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Tyruko Europeiska unionen - spanska - EMA (European Medicines Agency)

tyruko

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - inmunosupresores - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 y 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

METILPREDNISOLONA NORMON 20 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EFG Spanien - spanska - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

metilprednisolona normon 20 mg polvo y disolvente para solucion inyectable efg

laboratorios normon s.a. - metilprednisolona, hidrogenosuccinato de - polvo y disolvente para soluciÓn inyectable - 20 mg - metilprednisolona, hidrogenosuccinato de 20 mg - metilprednisolona

METILPREDNISOLONA NORMON 250 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EFG Spanien - spanska - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

metilprednisolona normon 250 mg polvo y disolvente para solucion inyectable efg

laboratorios normon, s.a. - metilprednisolona, hidrogenosuccinato de - excipientes: dihidrogenofosfato de disodio anhidro,dihidrogenofosfato de sodio monohidrato,hidroxido de sodio (e-524) - corticosteroides para uso sistÉmico, monofÁrmacos - glucocorticoides - metilprednisolona

METILPREDNISOLONA NORMON 40 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EFG Spanien - spanska - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

metilprednisolona normon 40 mg polvo y disolvente para solucion inyectable efg

laboratorios normon s.a. - metilprednisolona, hidrogenosuccinato de - polvo y disolvente para soluciÓn inyectable - 40 mg - metilprednisolona, hidrogenosuccinato de 40 mg - metilprednisolona